Immune and clinical outcomes in patients with stage IV melanoma vaccinated with peptide-pulsed dendritic cells derived from CD34+ progenitors and activated with type I interferon
Jacques Banchereau, Hideki Ueno, Madhav Dhodapkar, John Connolly, Jennifer P. Finholt, Eynav Klechevsky, Jean Philippe Blanch, Dennis A. Johnston, A. Karolina Palucka, Joseph Fay
Research output: Contribution to journal › Article › peer-review
122Scopus
citations
Fingerprint
Dive into the research topics of 'Immune and clinical outcomes in patients with stage IV melanoma vaccinated with peptide-pulsed dendritic cells derived from CD34+ progenitors and activated with type I interferon'. Together they form a unique fingerprint.